These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35678000)

  • 21. Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior.
    Hartleb M; Gutkowski K; Zejda JE; Chudek J; Więcek A
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1288-95. PubMed ID: 22864260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of hepatitis B, C and D in Malawi: systematic review.
    Stockdale AJ; Mitambo C; Everett D; Geretti AM; Gordon MA
    BMC Infect Dis; 2018 Oct; 18(1):516. PubMed ID: 30314448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocellular carcinoma and its early detection by AFP testing in Mongolia.
    Oyunsuren T; Sanduijav R; Davaadorj D; Nansalmaa D
    Asian Pac J Cancer Prev; 2006; 7(3):460-2. PubMed ID: 17059345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B, C, and delta in the general population in Mayotte: hepatitis B as a major public health concern.
    Brouard C; Parenton F; Youssouf H; Chevaliez S; Gordien E; Jean M; Bruyand M; Vaux S; Lot F; Ruello M;
    BMC Infect Dis; 2022 Aug; 22(1):716. PubMed ID: 36038821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B, C, and D virus infection showing distinct patterns between injection drug users and the general population.
    Chen F; Zhang J; Guo F; Wen B; Luo S; Yuan D; Lin Y; Ou W; Tang P; Dai G; Li F; Liu W; Qu X
    J Gastroenterol Hepatol; 2017 Feb; 32(2):515-520. PubMed ID: 27248508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The burden and epidemiology of hepatitis B and hepatitis D in Georgia: findings from the national seroprevalence survey.
    Kasradze A; Shadaker S; Kuchuloria T; Gamkrelidze A; Nasrullah M; Gvinjilia L; Baliashvili D; Chitadze N; Kodani M; Tejada-Strop A; Drobeniuc J; Hagan L; Morgan J; Imnadze P; Averhoff F
    Public Health; 2020 Aug; 185():341-347. PubMed ID: 32738575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh.
    Ashraf H; Alam NH; Rothermundt C; Brooks A; Bardhan P; Hossain L; Salam MA; Hassan MS; Beglinger C; Gyr N
    BMC Infect Dis; 2010 Jul; 10():208. PubMed ID: 20630111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tracing hepatitis C and Delta viruses to estimate their contribution in HCC rates in Mongolia.
    Kurbanov F; Tanaka Y; Elkady A; Oyunsuren T; Mizokami M
    J Viral Hepat; 2007 Sep; 14(9):667-74. PubMed ID: 17697020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
    Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM
    J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence, co-infection and risk of transmission of Hepatitis B and D virus among hospital attendees in two South-western states in Nigeria.
    Sobajo OA; George UE; Osasona OG; Eromon P; Aborisade OY; Ajayi OD; Folarin OA; Komolafe IOO
    J Immunoassay Immunochem; 2023 Mar; 44(2):133-146. PubMed ID: 36369932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt.
    el-Sayed NM; Gomatos PJ; Rodier GR; Wierzba TF; Darwish A; Khashaba S; Arthur RR
    Am J Trop Med Hyg; 1996 Aug; 55(2):179-84. PubMed ID: 8780457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
    Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
    World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan.
    Husseini AA; Islam Saeed KM; Yurdcu E; Bozdayı AM
    Turk J Gastroenterol; 2020 Sep; 31(9):658-666. PubMed ID: 33090103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco.
    Baha W; Foullous A; Dersi N; They-they TP; El alaoui K; Nourichafi N; Oukkache B; Lazar F; Benjelloun S; Ennaji MM; Elmalki A; Mifdal H; Bennani A
    BMC Public Health; 2013 Jan; 13():50. PubMed ID: 23331910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
    Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Galimany R; Esteban R; Guardia J
    Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of HBV, HDV, HCV, and HIV infection during pregnancy in northern Benin.
    De Paschale M; Ceriani C; Cerulli T; Cagnin D; Cavallari S; Ndayaké J; Zaongo D; Priuli G; Viganò P; Clerici P
    J Med Virol; 2014 Aug; 86(8):1281-7. PubMed ID: 24777580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotype and subtype analyses of hepatitis B virus (HBV) and possible co-infection of HBV and hepatitis C virus (HCV) or hepatitis D virus (HDV) in blood donors, patients with chronic liver disease and patients on hemodialysis in Surabaya, Indonesia.
    Lusida MI; Surayah ; Sakugawa H; Nagano-Fujii M; Soetjipto ; Mulyanto ; Handajani R; Boediwarsono ; Setiawan PB; Nidom CA; Ohgimoto S; Hotta H
    Microbiol Immunol; 2003; 47(12):969-75. PubMed ID: 14695447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence of hepatitis B and delta viruses among HIV-infected population attending anti-retroviral clinic in selected health facilities in Abuja, Nigeria.
    Ifeorah IM; Bakarey AS; Adeniji JA; Onyemelukwe FN
    J Immunoassay Immunochem; 2017; 38(6):608-619. PubMed ID: 28854102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence of hepatitis B virus and hepatitis C virus co-infection among people living with HIV/AIDS visiting antiretroviral therapy centres in Nepal: a first nationally representative study.
    Ionita G; Malviya A; Rajbhandari R; Schluter WW; Sharma G; Kakchapati S; Rijal S; Dixit S
    Int J Infect Dis; 2017 Jul; 60():64-69. PubMed ID: 28483724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing seroepidemiology of hepatitis B, C, and D virus infections in high-risk populations.
    Huo TI; Wu JC; Wu SI; Chang AL; Lin SK; Pan CH; Huang YH; Chang FY; Lee SD
    J Med Virol; 2004 Jan; 72(1):41-5. PubMed ID: 14635009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.